261 related articles for article (PubMed ID: 9372964)
1. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein.
You M; Ku PT; Hrdlicková R; Bose HR
Mol Cell Biol; 1997 Dec; 17(12):7328-41. PubMed ID: 9372964
[TBL] [Abstract][Full Text] [Related]
2. Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display.
You M; Bose HR
Methods; 1998 Dec; 16(4):373-85. PubMed ID: 10049645
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel.
Kralova J; Liss AS; Bargmann W; Pendleton C; Varadarajan J; Ulug E; Bose HR
J Virol; 2002 Dec; 76(23):11960-70. PubMed ID: 12414938
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins.
White DW; Gilmore TD
Oncogene; 1996 Sep; 13(5):891-9. PubMed ID: 8806678
[TBL] [Abstract][Full Text] [Related]
5. The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells.
White DW; Roy A; Gilmore TD
Oncogene; 1995 Mar; 10(5):857-68. PubMed ID: 7898928
[TBL] [Abstract][Full Text] [Related]
6. The inhibitors of apoptosis (IAPs) and their emerging role in cancer.
LaCasse EC; Baird S; Korneluk RG; MacKenzie AE
Oncogene; 1998 Dec; 17(25):3247-59. PubMed ID: 9916987
[TBL] [Abstract][Full Text] [Related]
7. NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
Sif S; Gilmore TD
J Virol; 1993 Dec; 67(12):7612-7. PubMed ID: 8230480
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.
Hrdlicková R; Nehyba J; Bose HR
J Virol; 1995 Jun; 69(6):3369-80. PubMed ID: 7745683
[TBL] [Abstract][Full Text] [Related]
9. p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
Capobianco AJ; Chang D; Mosialos G; Gilmore TD
J Virol; 1992 Jun; 66(6):3758-67. PubMed ID: 1533881
[TBL] [Abstract][Full Text] [Related]
10. v-rel Induces ectopic expression of an adhesion molecule, DM-GRASP, during B-lymphoma development.
Zhang G; Slaughter C; Humphries EH
Mol Cell Biol; 1995 Mar; 15(3):1806-16. PubMed ID: 7862170
[TBL] [Abstract][Full Text] [Related]
11. Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein.
Chen C; Agnès F; Gélinas C
Mol Cell Biol; 1999 Jan; 19(1):307-16. PubMed ID: 9858554
[TBL] [Abstract][Full Text] [Related]
12. v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death.
Zong WX; Farrell M; Bash J; Gélinas C
Oncogene; 1997 Aug; 15(8):971-80. PubMed ID: 9285692
[TBL] [Abstract][Full Text] [Related]
13. A protein kinase-A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel.
Mosialos G; Hamer P; Capobianco AJ; Laursen RA; Gilmore TD
Mol Cell Biol; 1991 Dec; 11(12):5867-77. PubMed ID: 1944267
[TBL] [Abstract][Full Text] [Related]
14. Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins.
Diehl JA; McKinsey TA; Hannink M
Mol Cell Biol; 1993 Mar; 13(3):1769-78. PubMed ID: 8441412
[TBL] [Abstract][Full Text] [Related]
15. Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture.
Topol LZ; Marx M; Laugier D; Bogdanova NN; Boubnov NV; Clausen PA; Calothy G; Blair DG
Mol Cell Biol; 1997 Aug; 17(8):4801-10. PubMed ID: 9234736
[TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts.
Hrdlicková R; Nehyba J; Bose HR
Mol Cell Biol; 2001 Oct; 21(19):6369-86. PubMed ID: 11533227
[TBL] [Abstract][Full Text] [Related]
17. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.
White DW; Pitoc GA; Gilmore TD
Mol Cell Biol; 1996 Mar; 16(3):1169-78. PubMed ID: 8622661
[TBL] [Abstract][Full Text] [Related]
19. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
[TBL] [Abstract][Full Text] [Related]
20. Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.
Kralova J; Schatzle JD; Bargmann W; Bose HR
J Virol; 1994 Apr; 68(4):2073-83. PubMed ID: 8138992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
